Articles related to ANXIETY

Celebrity disclosures about using beta blockers for performance anxiety are prompting patient questions in primary care, reviving a decades-old off-label use with a comparatively lower risk profile than benzodiazepines.

A 14-year-old athlete presenting with exertional dyspnea and partial albuterol response prompted a structured biopsychosocial workup that revealed anxiety disorder rather than exercise-induced asthma as the primary driver.

Approach-withdrawal behavioral patterns — including dysregulated negative affect and resistance to routine change — showed moderate associations with co-occurring internalizing and externalizing symptoms in a cohort of 280 children with autism.

Viatris recalled one lot of Xanax XR 3-mg extended-release tablets after failed dissolution testing, with the FDA classifying the action as Class II and reporting no adverse events to date.

“Semaglutide and, to a lesser extent, liraglutide were associated with significantly lower risk of worsening mental illness.” – Lead Study Researcher Heidi Taipale, PhD, University of Eastern Finland and Niuvanniemi Hospital

The authors suggest that an effective, smartphone-delivered CBT program could expand access to first-line treatment for GAD—particularly in settings where traditional therapy is difficult to obtain.